A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine

Dermatol Ther. 2022 Nov;35(11):e15812. doi: 10.1111/dth.15812. Epub 2022 Sep 24.

Abstract

Cutaneous pseudolymphomas (CPL) is a group of benign, reactive, and polyclonal lymphoproliferative dermatoses that simulate cutaneous lymphomas (CL) clinically and histologically. Based on the predominating component of lymphocytic infiltrate, CPL can be divided into cutaneous B-cell pseudolymphomas (CBPL), cutaneous T-cell pseudolymphomas (CTPL), mixed (T-/B-cell) pseudolymphomas, CD30-positive pseudolymphomas, and non-classifiable pseudolymphomas. Most patients with localized nodular CBPL present with a solitary nodule. However, few patients develop multiple skin lesions, rarely in generalized forms. Here we describe a rare case of multiple nodular CBPL on both sides of the patient's neck, which was treated successfully with intramuscular injection of compound betamethasone, oral methotrexate, and hydroxychloroquine for 4 months. No recurrence was observed in the patient at the one-year follow-up. This combined treatment may be a promising treatment choice for multiple nodular CBPL.

Keywords: B-cell pseudolymphomas; case report; cutaneous pseudolymphomas; multiple nodules.

Publication types

  • Case Reports

MeSH terms

  • Diagnosis, Differential
  • Glucocorticoids / therapeutic use
  • Humans
  • Hydroxychloroquine / therapeutic use
  • Methotrexate / therapeutic use
  • Pseudolymphoma* / diagnosis
  • Pseudolymphoma* / drug therapy
  • Pseudolymphoma* / pathology
  • Skin Diseases* / diagnosis
  • Skin Diseases* / drug therapy
  • Skin Diseases* / pathology
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / pathology

Substances

  • Methotrexate
  • Hydroxychloroquine
  • Glucocorticoids